XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.20.2

Restructuring Charges, Net of Reversals and Impairment, and Related Charges | 3 Months Ended
--- | ---
Sep. 30, 2020
Restructuring And Related Activities [Abstract] |
Restructuring Charges, net of reversals, impairment, and related charges |
14. | Restructuring Charges, Net of Reversals, Impairment, and Related Charges.
The Company recorded $1.0 million of restructuring charges, net of reversals and impairments during the three months ended September 30, 2020 which included severance and benefits charges of $0.7 million and facility related charges of $0.3 million. Severance and benefit restructuring charges consisted primarily of additional employee severance and benefit expenses incurred under the reduction-in-force action initiated in the third quarter of fiscal 2020 (the “2020 Plan”) to reduce operating costs and enhance financial flexibility as a result of disruptions caused by the COVID-19 global pandemic. The Company incurred $8.8 million of charges under the 2020 Plan through September 30, 2020. With the reduction and realignment of the headcount under the 2020 Plan, the Company is relocating certain of its lab test equipment to third-party consulting companies. The Company expects to incur equipment related relocation expenses of approximately $1.0 million related to these activities and expects to substantially complete these activities by the end of fiscal 2021. The facility restructuring charges included additional facilities expenses related to previously impaired facilities. The Company recorded $6.1 million of restructuring charges, net of reversals and impairment during the three months ended September 30, 2019, including charges of $3.9 million for right-of-use assets related to facilities which the Company has exited during the period and employee severance and benefit expenses of $2.2 million incurred under the Company’s restructuring plans initiated in prior years which were complete as of the end of fiscal 2020. Restructuring liabilities related to severance and benefits obligations are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. The following table summarizes the activity related to the severance and benefits related equipment restructuring liabilities during the three months ended September 30, 2020 and 2019 (in thousands):
|  | Three Months Ended |
|  | September 30, 2020 |  |  | September 30, 2019 |
|  | Severance Benefits |  |  | Severance Benefits |
Balance as of June 30, 2020 |  | $ | 2,219 |  |  | $ | 3,559 |
Period charges |  |  | 772 |  |  |  | 2,595 |
Period reversals |  |  | (50 | ) |  |  | (409 | )
Period payments |  |  | (2,639 | ) |  |  | (3,608 | )
Balance as of September 30, 2020 |  | $ | 302 |  |  | $ | 2,137 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -URI http://asc.fasb.org/topic&trid=2175745 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration